Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de recherche
Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial
Nagy S, Hafner P, Schmidt S, et al.
Trials, 2019, 20, 1, p 637
Effect of Combination l-Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
Hafner P, Bonati U, Klein A, et al.
JAMA network open, 2019, 2, 10
Psychosocial adjustment and parental stress in Duchenne Muscular Dystrophy
Gocheva V, Schmidt S, Orsini AL, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2019
Association Between Health-Related Quality of Life and Motor Function in Ambulant and Nonambulant Duchenne Muscular Dystrophy Patients
Gocheva V, Schmidt S, Orsini AL, et al.
Journal of child neurology, 2019
Longitudinal reliability of outcome measures in patients with Duchenne muscular dystrophy
Nagy S, Schädelin S, Hafner P, et al.
Muscle & Nerve, 2019
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Nagy S, Schmidt S, Hafner P, et al.
Journal of visualized experiments : JoVE, 2019, 143
Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis
Schmidt S, Hafner P, Klein A, et al.
Neuromuscular disorders : NMD, 2018, 28, 1, p 16
Facioscapulo humeral muscular dystrophy, glucose metabolism and insulin resistance
Pakula A, Mahler A, Schmidt S, et al.
Congrès : 4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France))
2011, p. 157-158
Cardiac involvement in sporadic inclusion-body myositis
Utz W, Schmidt S, Schulz-Menger J, et al.
Circulation, 2010, 121, 5, p. 706-708
Dysferlin-deficient muscular dystrophy : gadofluorine M suitability at MR imaging in a mouse model
Schmidt S, Vieweger A, Obst M, et al.
Radiology, 2009, 250, 1, p. 87-94
Is complement inhibition a potential therapy in dysferlin-deficient muscular dystrophy ? (Poster)
Collectif, Schowel V, Zabojsczca J, et al.
Neuromuscular disorders : NMD, 2008, 18, 9-10, p. 791
Late onset immunodeficiency in a patient with recurrent thymic carcinoma and myasthenia gravis
Schmidt S, Padberg F
Journal of the neurological sciences, 1998, 157, 2, p. 201-205
